WIPO Re:Search Celebrates 3 Years, Looks To The Future 20/01/2015 by William New and Catherine Saez, Intellectual Property Watch Leave a Comment Several years ago, the World Intellectual Property Organization set up a project aimed at helping bring together those with intellectual property rights and those with ideas for research to develop medical products for people in need. The project, WIPO Re:Search, has gathered numerous partners and is beginning to look ahead to its next phases, including the possible eventuality of drug development, according to the WIPO secretariat.
Year Ahead: Copyright Reform, EPO Governance, Trade Secrets Among Top European IP Issues In 2015 19/01/2015 by Dugie Standeford for Intellectual Property Watch Leave a Comment Review, and possibly reform, of the European Union copyright system tops the list of “hot” European intellectual property issues this year. The new European Commission has made modernising copyright rules a major priority, while fresh debate has broken out over the need for levies on digital copying devices to remunerate rights holders. Meanwhile ongoing unrest between European Patent Office (EPO) staff and management looks likely to continue, as do efforts to finalise the unitary European patent and Unified Patent Court. EU legislation to protect trade secrets could be adopted and trademark law updated. In addition, several important IP-related decisions are expected from the European Court of Justice (ECJ).
WHO Report: Access, Affordability Of Medicines Key To Reducing Non-Communicable Diseases 19/01/2015 by James Cote for Intellectual Property Watch 1 Comment A new report from the World Health Organization examines the Global action plan for the prevention and control of noncommunicable diseases 2013-2020 (known as the Global NCD Action Plan) and provides some “lessons learnt from implementation.” The report calls for urgent action by governments to stop the “epidemic” of cancer and mostly preventable diseases from sources like tobacco use, salt intake, physical inactivity, and high blood pressure. This includes ensuring treatment is available and affordable, it says.
Gilead To Appeal India Patent Rejection, Hails Regulatory Approval 16/01/2015 by William New, Intellectual Property Watch 2 Comments Pharmaceutical manufacturer Gilead has given its side to this week’s story of the rejection of its patent on a hepatitis C treatment in India, and it insists it will prevail in making its medicines available in India on its terms.
Key Hepatitis C Patent Rejected In India 14/01/2015 by William New, Intellectual Property Watch 10 Comments Today’s rejection by the Patent Office Controller of India of a patent application by Gilead company for a key drug against hepatitis C is being hailed by advocates as a path to dramatically lower costs of treatment for the disease. Hepatitis C has been noteworthy for exorbitantly priced medicines over the past year. A look at the decision shows that a provision in India’s law continues to stop patent applications if they fail to show sufficient novelty and inventive step – and are subject to opposition.
WHO Executive Board To Address Reform, R&D Financing, Ebola, Budget 14/01/2015 by Catherine Saez, Intellectual Property Watch 2 Comments The upcoming World Health Organization Executive Board annual January meeting will be 10 days. Included in the list of issues to be addressed are the engagement of the organisation with lobbyists and donors, antimicrobial resistance, and the potential establishment of a pooled fund of voluntary contributions for research and development for diseases primarily affecting developing countries.
Panels Look At Proposed EU, French Trade Secret Legislations 13/01/2015 by Magda Voltolini for Intellectual Property Watch Leave a Comment PARIS – French government officials and industry representatives gathered here recently to debate proposed new rules to protect trade secrets against unlawful acquisition, use and disclosure.
Top European IP Experts Hail CEIPI’s 50 Years With Vision, Suggestions For IP System 12/01/2015 by Elena Bourtchouladze for Intellectual Property Watch, James Cote for Intellectual Property Watch and Catherine Saez Leave a Comment The celebration late last year of the 50th anniversary of the Centre de Études Internationales de la Propriété Intellectuelle (CEIPI) at the Université de Strasbourg, France, brought together leading figures in the European IP community. Speakers hailed the origin and successes of the IP system in Europe, and had suggestions for what do better going forward.
India’s Draft IP Policy Shows Major Changes Coming, While Fitting IP System To Local Needs 08/01/2015 by William New, Intellectual Property Watch 4 Comments The first draft of a national intellectual property rights policy being developed by a “think tank” of Indian IP experts shows adherence to the country’s principles of bending the IP system to its local needs. But it also shows signs of major change toward more international goals of enforcement and promotion of strong IP rights.
Special Report: Strictly Business: US IP Attachés Report Home 24/12/2014 by William New, Intellectual Property Watch Leave a Comment WASHINGTON, DC – Last week was ‘old home week’ for officials in the United States intellectual property attaché program, as they returned before the holidays from their posts around the world. Speaking publicly, the officials gave mixed reports on the fight to advance IP rights worldwide. They also heard harsh but determined words about the situation in Geneva from the industry perspective. Two more attaché offices will open next year, and several attachés last week called for an elevation in their rank in order to enable them to have access to higher level officials in other countries.